“Immunotoxin – a new treatment option in patients with relapsed and refractory Hodgkin lymphoma”, Radiol Oncol, vol. 49, no. 4, Jan. 2016, Accessed: Nov. 01, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/2433